Relationship between antibiotic exposure and subsequent Clostridium difficile-associated diarrhea

Hospital Pharmacy

Volumn 42, Issue 5, 2007, Pages 430-434

  Minson, Quentin ^a   Mok, Steve ^a  

^a CENTENNIAL MEDICAL CENTER   (United States)

Author keywords

Antibiotic associated colitis; Antibiotics; Clostridium difficile; Diarrhea

Indexed keywords

AMINOGLYCOSIDE; AMINOPENICILLIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFEPIME; CEPHALOSPORIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; GLYCOPEPTIDE; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DIARRHEA; DRUG USE; FEMALE; HOSPITAL PATIENT; HUMAN; IMMUNOASSAY; MALE; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 34249936648     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1310/hpj4205-430     Document Type: Article

References (10)

1. Hurley BW, Nguyen CC. The spectrum of pseudomembranous enteroocolitis and antibiotic-associated diarrhea. Arch Intern Med. 2002;162:2117-2184.
2. Riley TV. Nosocomial diarrhoea due to Clostridium difficile. Curr Opin Infect Dis. 2004;17:323-327.
3. McCusker ME, Harris AD, Perencevich E, Roghmann MC. Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg Infect Dis. 2003;9:730-733.
4. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40:1-15.
5. Wilcox MH, Freeman J, Fawley W, et al. Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. J Antimicrob Chemother. 2004;54:168-172.
6. Wistrom J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2,462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother. 2001;47:43-50.
7. Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile- associated diarrhea: a review. Arch Intern Med. 2001;161:525-533.
8. Wilcox MH, Fawley WN. Hospital disinfectants and spore formation by Clostridium difficile. Lancet. 2000; 356:1324.
9. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41:1254-1260.
10. Yip C, Loeb M, Salama S, Moss L, Olde J. Quinolone use as a risk factor for nosocomial Clostridium difficile-associated diarrhea. Infect Control Hosp Epidemiol. 2001;22:572-575.